Category Archives: healthcare

‘Warehousing’ and the Future of HCV Treatment

The battle against hepatitis C (HCV) is a relatively new, and highly dynamic, one.  The viral disease was only discovered in the 1980’s and, according to WHO estimates, some 3% of the world’s population are now infected with HCV and there are more than 170 million chronic carriers. So what does the HCV treatment landscape look […]
Also posted in Strategy | Tagged , , | Leave a comment

Dental Health: The Heart-Disease Puzzle’s Missing Piece?

“At least she has her teeth,” my grandmother would say when gossiping about a friend. My grandmother had none of her’s and took her dentures out every night and put them in a glass of water by her bed. Growing up it was clear to me that dental health did not afford the same import […]
Posted in healthcare | Tagged , , | Leave a comment

New Republican Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy

The 2014 mid-term elections handed over control of the Senate to Republicans and boosted the GOP majority in the House, a clear blow to Obama administration policies, including the president’s landmark health reform initiative.  Voters were most dismayed about the economy and lack of jobs, but U.S. military snafus overseas and concerns about the Ebola […]
Also posted in Op-Ed, Regulatory | Tagged , , , , , , | Leave a comment

Legislators Urge Added Incentives for Ebola Drug Development

Leading Senators are proposing legislation to add Ebola to the list of diseases eligible for priority review vouchers from the Food and Drug Administration as an incentive for biopharma companies to invest in treatments for this deadly disease. The priority review voucher (PRV) program for neglected tropical diseases (NTDs) currently applies to 16 deadly conditions […]
Also posted in Regulatory | Tagged , , , , | Leave a comment

US Healthcare Reform: A Pharm Exec Digest Special

This month’s special issue of Pharm Exec Global Digest looks at Dealing with the “side effects” of Obamacare The “value” of Rxs under Obamacare The escalating cost of US oncology care And more… Click here to read the issue.
Also posted in Global, Regulatory | Tagged , , , | Leave a comment
  • Categories

  • Meta